Phase 1/2 study of the safety and efficacy of APL-101, a specific c-MET inhibitor

Autor:	Anthony B. El-Khoueiry, Elizabeth Claire Dees, G. Choy, A. Luria, Patrick C. Ma, N. Sankar, J. Jenab-Wolcott, K. Mody, Mark E. Burkard, L. Espiritu, X. Zhang, S. H. Kizilbash, Mohammed Almubarak, Fabio Benedetti, Michael J. Guarino, R. E. Lerner
Rok vydání:	2020
Předmět:	c-Met inhibitor Cancer Research Oncology business.industry Phase (matter) Medicine Pharmacology business
Zdroj:	European Journal of Cancer. 138:S11-S12
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0315a545d566a1b9fae5228612747760 https://doi.org/10.1016/s0959-8049(20)31095-9 Zobrazit plný text záznamu Full Text from ScienceDirect